MCISX
Price
$21.64
Change
+$0.17 (+0.79%)
Updated
Aug 21 closing price
Net Assets
4.62B
VFSNX
Price
$305.26
Change
+$2.21 (+0.73%)
Updated
Aug 21 closing price
Net Assets
13.55B
Interact to see
Advertisement

MCISX vs VFSNX

MCISX vs VFSNX Comparison Chart in %
View a ticker or compare two or three
VS
MCISX vs. VFSNX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCISX is a StrongBuy and VFSNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFSNX has more cash in the bank: 13.6B vs. MCISX (4.62B). VFSNX pays higher dividends than MCISX: VFSNX (3.29) vs MCISX (0.93). MCISX was incepted earlier than VFSNX: MCISX (19 years) vs VFSNX (17 years). MCISX (3.49) is less costly to investors than VFSNX (0.08). MCISX is a more actively managed with annual turnover of: 49.00 vs. VFSNX (27.00). MCISX has a lower initial minimum investment than VFSNX: MCISX (2500) vs VFSNX (5000000). MCISX (17.84) and VFSNX (17.32) have marching annual gain over last year. MCISX (27.48) and VFSNX (26.57) have equivalent 5 years return.
MCISXVFSNXMCISX / VFSNX
Total Expense Ratio2.100.082,625%
Annual Report Gross Expense Ratio3.490.084,363%
Fund Existence19 years17 years-
Gain YTD13.00311.725111%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.62B13.6B34%
Annual Yield % from dividends0.933.2928%
Returns for 1 year17.8417.32103%
Returns for 3 years68.5253.10129%
Returns for 5 years27.4826.57103%
Returns for 10 years103.4581.31127%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRMA1.420.04
+2.90%
Dermata Therapeutics Inc
NIC173.231.54
+0.90%
Nicolet BanksharesInc
INV1.510.01
+0.67%
Innventure Inc
INCY127.810.59
+0.46%
Incyte Corp
SCHL40.140.16
+0.40%
Scholastic Corp